Showing 3561-3570 of 9114 results for "".
New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc/23268/Keeping Our Eyes on the Prize
https://practicaldermatology.com/topics/practice-management/keeping-our-eyes-on-the-prize/20392/Breaking Up The Band: Targeting Cellulite
https://practicaldermatology.com/topics/practice-management/breaking-up-the-band-targeting-cellulite/20704/Patient selection is key to long-lasting, consistent results with Cellfina.Regression in Primary Melanomas: Histologic Factors and Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/regression-in-primary-melanomas-histologic-factors-and-prognosis/21367/Regression was once thought to be a negative prognostic factor in primary melanomas, but new findings suggest otherwise.IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officia?Understand and Correct Common Claim Denials
https://practicaldermatology.com/topics/general-topics/PD0109_09-php/22896/A review of some common causes for claim denials identifies strategies for obtaining proper reimbursement.Keratosis Pilaris: A Rough and Bumpy Review
https://practicaldermatology.com/columns/clinical-focus-1/keratosis-pilaris-a-rough-and-bumpy-review/23618/There are promising interventions for this challenging presentation.Science of Skincare Summit 2024:What's Going On With Medical Dermatology?
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-whats-going-on-with-medical-dermatology/29451/Todd Schlesinger, MD, James Del Rosso, DO, and Neal Bhatia, MD, discuss challenges facing medical dermatology, and what can be done to save it, as well as the importance of encouraging young dermatologists to become involved with clinical research. This discussion was recorded at the Science of SkinDiverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyA Peak Inside the Psoriasis Pipeline
https://practicaldermatology.com/columns/clinical-focus-1/special-edition-what-i-did-on-my-summer-vacation/23803/Here’s a look at what’s here today and what is coming down the pike for psoriasis patients.